Clinical Trial Update: An Open-Label Study of Azetukalner in Major Depressive Disorder [Phase 3]

View source ↗

Summary

An open-label Phase 3 clinical trial evaluating azetukalner for Major Depressive Disorder is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Azetukalner

Snippet

Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: ENROLLING_BY_INVITATION